IL1A and tuberculosis: Since immune-suppressive treatments, including anakinra (12, –, 14), are associated with an increased risk of the development of TB, it is tempting to speculate that enhancing IL-1 signaling without causing excessive inflammation may be helpful in protecting the host from TB disease progression.